Differential expression of intracellular and extracellular CB2 cannabinoid receptor protein by human peripheral blood leukocytes

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 1, 2013, Pages 323-332

  Castaneda, Julie T ^a   Harui, Airi ^a   Kiertscher, Sylvia M ^a   Roth, Jeffrey D ^a   Roth, Michael D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabinoid receptor CB2; Cannabinoids; G protein coupled receptors; Imaging flow cytometry; Intracellular membrane receptors; Leukocytes; Tetrahydrocannabinol

Indexed keywords

CANNABINOID 2 RECEPTOR; GREEN FLUORESCENT PROTEIN; TETRAHYDROCANNABINOL;

ARTICLE; B LYMPHOCYTE; CELL PERMEABILIZATION; CELL STRAIN HEK293; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR MEMBRANE; LEUKOCYTE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; FLOW CYTOMETRY; HUMANS; INTRACELLULAR SPACE; LEUKOCYTES; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, CANNABINOID, CB2; T-LYMPHOCYTES; TETRAHYDROCANNABINOL;

EID: 84874648902     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9430-8     Document Type: Article

References (39)

1. 2) mediates immunoglobulin class switching from IgM to IgE in cultures of murine-purified B lymphocytes. J Neuroimmune Pharmacol 3:35-42
2. 2 ligands. Mol Pharmacol 81:250-263
3. 2) immune regulation in health and disease. Immunol Res 51:26-38
4. Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D, Le Fur G, Casellas P (1993) Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 214:173-180
5. 1 cannabinoid receptors are activated by anandamide. J Biol Chem 286:29166-29174
6. 2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92:3605-3615
7. 2 receptors. PLoS One 5:e8688
8. Dainese E, Oddi S, Maccarrone M (2010) Interaction of endocannabinoid receptors with biological membranes. Curr Med Chem 17:1487-1499
9. Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2004) Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J Immunol 173:2373-2382
10. Galiègue S, Mary S, Marchand J, Dussossoy D, Carrière D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61
11. 2 receptor agonist in a murine model of neuroAIDS. J Neuroimmune Pharm 5:456-468
12. 2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry. Int J Immunopathol Pharmacol 23:25-34
13. Grimsey NL, Goodfellow CE, Dragunow M, Glass M (2011) Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway. Biochim Biophys Acta 1813:1554-1560
14. 2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol 153:319-334
15. Howlett AC (2005) Cannabinoid receptor signaling. Handb Exp Pharmacol 168:53-79
16. Jean-Alphonse F, Hanyaloglu AC (2011) Regulation of GPCR signal networks via membrane trafficking. Mol Cell Endocrinol 331:205-214
17. Klein TW, Newton CA, Nakachi N, Friedman H (2000) Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol 164:6461-6466
18. Klein TW (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5:400-411
19. Klein TW, Cabral GA (2006) Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. J Neuroimmune Pharm 1:50-64
20. Mach F, Steffens S (2008) The role of the endocannabinoid system in atherosclerosis. J Neuroendocrinol 20:S53-S57
21. Mackie B (2006) Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 46:101-122
22. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. PNAS 97:9561-9566
23. McKallip RJ, Lombard C, Martin BR, Nagarkatti M, Nagarkatti PS (2002) Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. J Pharmacol Exp Ther 302:451-465
24. McKallip RJ, Nagarkatti M, Nagarkatti PS (2005) Delta-9- tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 174:3281-3289
25. Mechoulam R (1986) The pharmacohistory of Cannabis sativa. In: Mechoulam R (ed) Cannabinoids as therapeutic agents. CRC Press, Boca Raton, pp 1-19
26. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
27. Newton CA, Chou PJ, Perkins I, Klein TW (2009) CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection. J Neuroimmune Pharm 4:92-102
28. Pertwee RG (2006) Cannabinoid pharmacology: the first 66 years. Br J Pharmacol 147:S163-S171
29. Roth MD, Tashkin DP, Whittaker KM, Choi R, Baldwin GC (2005) Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse. Life Sci 77:1711-1722
30. Rozenfeld R (2011) Type I cannabinoid receptor trafficking: all roads lead to lysosome. Traffic 12:12-18
31. 2 receptor-dependent and independent effects of THC on human lung epithelial cells. Toxicol Appl Pharmacol 231:282-290
32. 2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142:278-287
33. Shay A, Choi R, Whittaker K, Salehi K, Tashkin DP, Roth MD, Baldwin GC (2003) Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine. J Infect Dis 187:700-704
34. 2 peripheral cannabinoid receptor. Biochim Biophys Acta 1307:132-136
35. 2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol 78:231-238
36. 9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 40:179-185
37. Thomas BF, Compton DR, Martin BR (1990) Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency. J Pharmacol Exp Ther 255:624-630
38. 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T-cells. J Neuroimmunol 133:124-131
39. 2 receptor-mediated, cytokine-dependent pathway. J Immunol 165:373-380